Glaucoma:

Indications for Carteolol HCl Ophthalmic Solution:

Open-angle glaucoma. Ocular hypertension.

Adult Dosage:

1 drop in affected eye(s) twice daily. Concomitant pilocarpine and other miotics, and/or epinephrine or dipivefrin, and/or systemically administered carbonic anhydrase inhibitors may be used if needed.

Children Dosage:

Not established.

Carteolol HCl Ophthalmic Solution Contraindications:

Sinus bradycardia. Greater than 1st-degree AV block. Cardiogenic shock. Overt cardiac failure. Asthma. Severe COPD.

Carteolol HCl Ophthalmic Solution Warnings/Precautions:

History of cardiac failure or heart block. Discontinue at 1st sign of cardiac failure. Pulmonary impairment. Diabetes (esp. labile). May mask hypoglycemia and hyperthyroidism. May potentiate muscle weakness. Discontinue before general anesthesia. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers.

Carteolol HCl Ophthalmic Solution Classification:

Beta-blocker.

Carteolol HCl Ophthalmic Solution Interactions:

May potentiate or be potentiated by systemic β-blockers. May potentiate reserpine, hypoglycemics. May antagonize adrenergic psychotropics.

Adverse Reactions:

Ocular: transient eye irritation, burning, tearing, conjunctival hyperemia and edema, blurred/cloudy vision, photophobia, decreased night vision, ptosis; rarely: blepharoconjunctivitis, abnormal corneal staining, corneal sensitivity. Systemic: cardiac arrhythmia, heart palpitation, dyspnea, asthenia, headache, dizziness, insomnia, sinusitis, taste perversion.

Note:

Formerly known under the brand name Ocupress.

How Supplied:

Soln—5mL, 10mL, 15mL